Most Recent
A trade mark's reputation is beside the point in an infringement claim alleging deceptive similarity, the Full Federal Court heard Monday in an appeal of a case involving two of Australia's biggest meat processing and distribution companies.
E-retailer Catch Group has sued competitor Kogan, saying the online retailer is violating its "catch" trademarks and the consumer law through sponsored links on Google driven by phrases using the word "catch".
A technology company has won dismissal of a Federal Court case alleging its industrial machine safety system that uses laser beams to detect hazards infringed on a patent licensed to a rival.
In a major loss for the ACCC, the Full Federal Court on Friday tossed the competition regulator's challenge to a ruling that drug giant Pfizer did not misuse its market power in the months leading up to the expiration of the patent for its blockbuster cholesterol drug Lipitor.
Bega Cheese has brought new allegations against Kraft in their dispute over who owns the rights to the signature Kraft peanut butter packaging in Australia.
Gaming giant Aristocrat has commenced legal action against rival Ainsworth, claiming a “controversial” game designer used confidential information to develop a competing slot machine.
The judge overseeing a case brought by Meat & Livestock Australia over a bovine gene patent has given parties until July 5 to oppose changes to the patent, held by Cargill and Branhaven, after an earlier ruling invalidated the patent.
The ACCC will face a test of its ability to win misuse of market power cases when a long-awaited judgment is handed down this week in the regulator's appeal of a ruling dismissing its case alleging Pfizer misused its market power in the months leading up to the expiration of the patent for its blockbuster cholesterol drug Lipitor.
For the third time this year, IP Australia has upheld a challenge to a coffee capsule patent, finding that the patent, owned by a unit of German food giant Kruger, was not inventive.
Two generic drug makers are fighting for access to confidential documents related to amendments by Neurim Pharmaceutical of patents covering its sleep drug Circadin, telling the Federal Court on Thursday privilege had been waived after a phone conversation between the company's founder and her lawyers from DLA Piper.